Dysfunctional voiding confirmed by transdermal perineal electromyography, and its effective treatment with baclofen in women with lower urinary tract symptoms: a randomized double‐blind placebo‐controlled crossover trial

To assess the activity of baclofen, a potent γ‐aminobutyric acid‐ergic agonist, against dysfunctional voiding (DV) and lower urinary tract symptoms (LUTS) in a clinical trial, as DV is a leading cause of LUTS in women, but there is no effective treatment.

[1]  Linda Brubaker,et al.  Urinary incontinence in women , 2006, The Lancet.

[2]  B. Schurch,et al.  Can neurologic examination predict type of detrusor sphincter-dyssynergia in patients with spinal cord injury? , 2005, Urology.

[3]  A. Wein.  Single-institution experience in 110 patients with botulinum toxin a injection into bladder or urethra. , 2005, The Journal of urology.

[4]  M. Chancellor,et al.  Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. , 2005, Urology.

[5]  C. Fowler,et al.  Maximum urethral closure pressure and sphincter volume in women with urinary retention. , 2002, The Journal of urology.

[6]  Carolyn Margraf,et al.  Overactive bladder. , 2002, The American journal of nursing.

[7]  P. Hoebeke,et al.  One thousand video‐urodynamic studies in children with non‐neurogenic bladder sphincter dysfunction , 2001, BJU international.

[8]  H. Wessells,et al.  Use of tolterodine in children with dysfunctional voiding: an initial report. , 2001, The Journal of urology.

[9]  V. Nitti,et al.  Dysfunctional voiding in women. , 2001, The Journal of urology.

[10]  J. Blaivas.  Female lower urinary tract symptoms: pharmacotherapeutic consequences , 2000 .

[11]  J. Blaivas,et al.  Female lower urinary tract symptoms : pharmacotherapeutic consequences. Commentary , 2000 .

[12]  J. Blaivas,et al.  Bladder outlet obstruction nomogram for women with lower urinary tract symptomatology , 2000, Neurourology and urodynamics.

[13]  E. Messelink.  The overactive bladder and the role of the pelvic floor muscles , 1999, BJU international.

[14]  G. Holstege,et al.  The central control of micturition and continence: implications for urology , 1999, BJU international.

[15]  T. Christmas,et al.  Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome? , 1988, BMJ.

[16]  T. Moore.  Urinary retention in women , 1976, The British journal of clinical practice.

[17]  D. Griffiths,et al.  Third report on the standardisation of terminology of lower urinary tract function. Procedures related to the evaluation of micturition: pressure-flow relationships. Residual urine. , 1980, Scandinavian journal of urology and nephrology.